Merck Price Negotiation Lawsuit May Face Same Obstacles as 340B Takings Claims
Past 340B litigation highlights that takings challenges to the Medicare price negotiation program face an uphill battle.

Past 340B litigation highlights that takings challenges to the Medicare price negotiation program face an uphill battle.
Congress must take action to ensure these discounts benefit low-income 340B eligible patients, as intended.
A recent advisory opinion released by HHS left many 340B advocates hungry for answers and pharmaceutical manufacturers frustrated.